Archive for KalVista

KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise

October 16, 2020

KalVista Pharmaceuticals Reports First Fiscal Quarter Results

September 15, 2020

KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results

July 8, 2020

KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise

January 13, 2020

KalVista Provides Business Update; Phase 2 Clinical Trial in HAE Expected to Complete Enrollment in 2019 with Data in 2020; Phase 2 Clinical Trial Data in DME Expected This Quarter

November 14, 2019

KalVista Pharmaceuticals Reports Fiscal First Quarter Results

September 10, 2019